EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A pretreatment TNM-metabolic vulnerability score with EBV DNA adjustment for risk stratification in non-metastatic nasopharyngeal carcinoma

Jinghua Zhong, Chunyan Zhou, Qiang Yi, Kui Zhong, Zheng Chen, Xinting Ouyang, Changyong Xu, Jiahua Liao, Weifeng Chen, Xiaojun Zhang

Frontiers in Oncology · 30.10.2026 · 16

DOI: 10.3389/fonc.2026.1914286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 30.10.2026. Verfasst von Jinghua Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

TNM stage and pretreatment plasma Epstein-Barr virus (EBV) DNA are central to risk assessment in nasopharyngeal carcinoma (NPC), but they do not fully capture host metabolic reserve.

Methods

We retrospectively analyzed 160 patients with non-metastatic NPC treated from 2013 to 2022. The integrated metabolic vulnerability score (IMVS; range, 0-3) assigned 1 point each for stage IVA, triglyceride-to-HDL cholesterol ratio <1.217, and body mass index <23.79 kg/m2. Cox regression and bootstrap internal validation evaluated progression-free survival (PFS), with EBV DNA included as an adjustment variable. A broader 271-patient cohort from the same institution was used only for internal sensitivity analysis.

Results

Thirty-three PFS events occurred in the modeling cohort. Five-year PFS was 100.0%, 91.9%, 72.1%, and 50.0% for IMVS scores 0, 1, 2, and 3, respectively. IMVS remained associated with PFS after adjustment for EBV DNA status (HR, 2.74; bootstrap percentile 95% CI, 1.89-4.75; P<0.001), although EBV DNA status itself was not independently significant in this cohort. The optimism-corrected AUC was 0.715 for stage IVA, THR, and BMI and 0.727 after adding EBV DNA. In the broader same-institution cohort, the association persisted but was attenuated (HR, 1.55; 95% CI, 1.14-2.10; P = 0.005).

Conclusion

IMVS is an exploratory, low-cost risk-stratification tool that may complement, rather than replace, TNM stage and plasma EBV DNA. Prospective external validation and recalibration of the data-derived thresholds are required before clinical use.

Schlagwörter

Stichwörter der Autor:innen

BMIEBV DNATHRbootstrap validationmetabolic vulnerabilitynasopharyngeal carcinomaridge Cox

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
  • The First Clinical Medical College, Gannan Medical University, Ganzhou, China.
  • Department of Oncology, Ma'anshan 17th Metallurgical Hospital, Ma'anshan, China.
  • Department of Otorhinolaryngology Head and Neck Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.

Zitieren

APA

Zhong, J., Zhou, C., Yi, Q., Zhong, K., Chen, Z., Ouyang, X., Xu, C., Liao, J., Chen, W., & Zhang, X. (2026). A pretreatment TNM-metabolic vulnerability score with EBV DNA adjustment for risk stratification in non-metastatic nasopharyngeal carcinoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1914286

Vancouver

Zhong J, Zhou C, Yi Q, Zhong K, Chen Z, Ouyang X, et al. A pretreatment TNM-metabolic vulnerability score with EBV DNA adjustment for risk stratification in non-metastatic nasopharyngeal carcinoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1914286

BibTeX
@article{Zhong2026,
  author = {Zhong, Jinghua and Zhou, Chunyan and Yi, Qiang and Zhong, Kui and Chen, Zheng and Ouyang, Xinting and Xu, Changyong and Liao, Jiahua and Chen, Weifeng and Zhang, Xiaojun},
  title = {A pretreatment TNM-metabolic vulnerability score with EBV DNA adjustment for risk stratification in non-metastatic nasopharyngeal carcinoma},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1914286}
}
Kostenlos starten →